1. Entecavir monotherapy improves renal function in patients developing renal side effects during long-term tenofovir treatment without compromising virological response: A multicenter real-life study in 103 patients. Issue 1 (16th February 2017) Authors: Viganò, M.; Grossi, G.; Loglio, A.; Cappelletti, M.; Zaltron, S.; Castelli, F.; Andreone, P.; Messina, V.; Ganga, R.; Coppola, N.; Marrone, A.; Russello, M.; Marzano, A.; Taliani, G.; Fasano, M.; Fagiuoli, S.; Villa, E.; Bronte, F.; Santantonio, T.; Brancaccio, G. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Epidemiology and clinical impact of non-viral acute hepatitis in a tertiary unit of Hepatology in Italy. Issue 3 (October 2018) Authors: Rizzi, F.; Adriani, A.; Morgando, A.; Alessandria, C.; Imperatrice, B.; Saracco, G.; Marzano, A. Journal: Digestive and liver disease Issue: Volume 50:Issue 3(2018)Supplement Page Start: e355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. HBV reactivation in pOBI is influenced by detectable viremia at baseline rather than duration of prophylaxis with lamivudine. Issue 1 (16th February 2017) Authors: Cavallo, F.; Ghione, P.; Battaglini, M.; Botto, B.; Caracciolo, D.; Ferrero, S.; Passera, R.; Vitolo, U.; Boccadoro, M.; Marzano, A. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of diastolic dysfunction (LVDD) on clinical response and prognosis after transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites. (February 2019) Authors: Venon, W. Debernardi; Del Galdo, M.T.; Boschini, M.; Imperatrice, B.; Giorgi, M.; Saracco, G.M.; Marzano, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Letter: renal effects of tenofovir in adefovir dipivoxil‐experienced HBV patients. Issue 3 (August 2014) Authors: Marengo, A.; Marietti, M.; Rizzetto, M.; Marzano, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 40:Issue 3(2014) Page Start: 324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Liver stiffness based model (LSPS) predicts measured portal hypertension (mPH), esophageal varices (EVs) and HCC in patients treated and responsive to DAA for HBV and HCV-related cirrhosis. Issue 1 (February 2018) Authors: Tucci, A.; Debernardi Venon, W.; Pelizza, M.; Chialà, C.; Ciancio, A.; Smedile, A.; Saracco, G.; Marzano, A. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Liver Stiffness Based Model (LSPS) predicts portal hypertension (PH), esofageal varices (EV) and HCC in Caucasian patients with HBV-related cirrhisis responsive to antiviral therapy. Issue 1 (16th February 2017) Authors: Tucci, A.; Debernardi Venon, W.; Chialà, C.; Fadda, M.; Saracco, G.M.; Marzano, A. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Liver stiffness-spleen size-to-platelet ratio risk score (LSPS) detects esophageal varices and HCC risk in HCV- and HBV-related cirrhosis responsive to DAA. (February 2019) Authors: Imperatrice, B.; Venon, W. Debernardi; Chialà, C.; Saracco, G.M.; Marzano, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Lusutrombopag treatment in cirrhotic patients with low platelets count scheduled to undergo invasive procedures: A multicenter experience. (March 2023) Authors: Tizzani, M.; Caneglias, A.; Frigo, F.; Gesualdo, M.; Airoldi, A.; Mazzarelli, C.; Iegri, C.; Fagiuoli, S.; Masutti, F.; Crocè, S.L.; Marzano, A. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The Italian ENTAS cohort study: Entecavir effectiveness in naïve and treatment experienced patients with chronic hepatitis B. (15th February 2015) Authors: Porro, E.; Di Leo, A.; Marzano, A.; Brancaccio, G.; Maimone, S.; Fasano, M.; Grasso, A.; Bronte, F.; Fagiuoli, S.; Santantonio, T.; Morisco, F.; Petrelli, E.; Surace, G.; Labbadia, G.; Badia, L.; Niro, G.A.; Vinci, M.; Montineri, A.; Vinelli, F.; Massari, M. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗